Is Vitamin B6 PMS Randomized Trial safe?

Updated June 2026

Quick Answer

Vitamin B6 PMS Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Moreover, taking such drugs during Ramadan has been reported to increase the risk of cerebral venous thrombosis [], and psychological resistance remains a major global challenge [].

Key Takeaways

  • 01Moreover, taking such drugs during Ramadan has been reported to increase the risk of cerebral venous thrombosis [], and psychological resistance remains a major global challenge []. [Iimura Jun (2026)]
  • 02For instance, Ahmadi reported that zinc supplementation reduced PMD symptoms [], and Tartagni reported the same for vitamin D []. [Iimura Jun (2026)]
  • 03As summarized by Carlini, there is insufficient evidence to recommend improvements through interventions with a single nutrient []. [Iimura Jun (2026)]
  • 041 2 3 4 5 Premenstrual disorder (PMD) is a serious issue for women across cultures, and is a comprehensive concept encompassing both physical and mental symptoms []. [Iimura Jun (2026)]
The current Migaku evidence database contains 2 reusable source documents for Vitamin B6 PMS Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Moreover, taking such drugs during Ramadan has been reported to increase the risk of cerebral venous thrombosis [], and psychological resistance remains a major global challenge []. [Iimura Jun (2026); evidence level 2] - For instance, Ahmadi reported that zinc supplementation reduced PMD symptoms [], and Tartagni reported the same for vitamin D []. [Iimura Jun (2026); evidence level 2] - As summarized by Carlini, there is insufficient evidence to recommend improvements through interventions with a single nutrient []. [Iimura Jun (2026); evidence level 2] - 1 2 3 4 5 Premenstrual disorder (PMD) is a serious issue for women across cultures, and is a comprehensive concept encompassing both physical and mental symptoms []. [Iimura Jun (2026); evidence level 2] - Some evidence suggests that women with Rh-negative blood type may have a higher likelihood of developing premenstrual symptoms, although mechanistic explanations remain speculative and findings are not yet consistent across studies. [Martire Francesco Giuseppe (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Novel dietary FemTech based on dietary reference intakes for premenstrual and menstrual disorders: a pilot open-label randomized controlled trial of dietary intervention
  2. Premenstrual Syndrome and Nutritional Factors: A Narrative Review of Current Evidence and Clinical Implications